Fortis Hospital, Gurugram Introduces India's First Centre of Excellence for Myeloma & Lymphoma
A landmark step in advancing blood cancer care, Fortis Hospital, Gurugram has launched India's First Centre of Excellence for Myeloma & Lymphoma under the Institute of Blood Disorders.
Speaking at the event, Dr. Rahul Bhargava, Principal Director & Chief – Bone Marrow Transplant, highlighted Fortis Gurugram's commitment to delivering world-class care through advanced technology, innovative treatment protocols, and expert multidisciplinary teams for patients battling Myeloma and Lymphoma.
Mr. Yash Rawat, Senior Vice President & SBU Head, Fortis Hospital, Gurugram, emphasized the hospital's patient-first approach and its dedication to providing cutting-edge technology, compassionate care, and the highest standards of clinical excellence.
The event also featured insightful discussions by experts from the Institute of Blood Disorders, who shared the latest advancements, treatment innovations, and future directions in the management of blood cancers.
Together, we continue to redefine cancer care and bring hope to patients and their families.


